Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity Offering Company now holds a total of 378 BTC (valued at ~$46 Million) CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announces the acquisition of 100 Bitcoin, at an average price of $109,594 per Bitcoin. This acquisition demonstrates the Company's dedication and continued discipline to building its Bitcoin treasury. Stra ...

Comprehensive Document Reveals Strategic Vision Behind Company's Unprecedented Growth and Bitcoin Treasury Strategy IM8, the Fastest-Growing Supplement Brand in Industry History, Reaching Reaches $100M ARR in 11 Months Since Launch IM Projects $180-$200 Million in FY 2026 Revenue CHARLOTTE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE (“Prenetics” or the “Company”), a leading health sciences company, today announced the publication of a comprehensive manifesto authored by CE ...

Core Viewpoint - Prenetics Global Limited has successfully closed a public offering, raising approximately $44 million to support its global expansion and Bitcoin accumulation strategy [3]. Group 1: Offering Details - The offering included 2,722,642 Class A ordinary shares and associated warrants, with a combined offering price of $16.08 per share [1]. - Class A Common Warrants have an exercise price of $24.12 per share, while Class B Common Warrants are priced at $32.16 per share, representing premiums of 50% and 100% respectively [2]. - The gross proceeds from the offering were approximately $44 million, down from a previously announced $48 million [3]. Group 2: Use of Proceeds - The proceeds will be utilized for the global expansion of IM8, Prenetics' flagship consumer brand, and for the strategic accumulation of Bitcoin as part of its health and wealth strategy [3][7]. - Prenetics has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 275 BTC as of October 27, 2025 [8]. Group 3: Company Background - Prenetics is a leading health sciences company co-founded with David Beckham, known for its rapid growth in the supplement industry, achieving $100 million in annual recurring revenue within 11 months of launch [7]. - The company is recognized for pioneering at the intersection of health innovation and digital assets [8].

Core Viewpoint - Prenetics Global Limited has successfully closed a public offering, raising approximately $44 million to support its global expansion and Bitcoin accumulation strategy [3]. Group 1: Offering Details - The offering included 2,722,642 Class A ordinary shares and associated warrants at a combined price of $16.08 per share [1]. - Class A Common Warrants have an exercise price of $24.12 per share, while Class B Common Warrants are priced at $32.16 per share, representing a 50% and 100% premium to the offering price respectively [2]. - The gross proceeds from the offering were approximately $44 million, which is lower than the previously announced $48 million [3]. Group 2: Use of Proceeds - The proceeds from the offering will be utilized for the global expansion of IM8, Prenetics' flagship consumer brand, and for the strategic accumulation of Bitcoin as part of its health and wealth strategy [3][7]. - Prenetics has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 275 BTC as of October 27, 2025 [8]. Group 3: Company Background - Prenetics is recognized as a leading health sciences company, co-founded with David Beckham, and has achieved $100 million in annual recurring revenue within 11 months of launching its IM8 brand, marking the fastest growth in the supplements industry [7].

JUST IN: Nasdaq-listed healthcare company Prenetics raises $48 MILLION to buy more BitcoinPrenetics has bought 1 Bitcoin per day since August 1Their long-term goal is to buy $1 BILLION Bitcoin by 2026 🔥 https://t.co/MtdrH8t8f6 ...

Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions World No. 1 and 4-time Grand Slam champion Aryna Sabalenka expands her stake in Prenetics Adrian Cheng, one of Asia’s most influential visionaries and an original cornerstone investor in Prenetics’ IPO increases his stake, reflecting enduring conviction in the company’s global vision IM8 Achieves $100 Million in Annual Recurring Revenue Withi ...

Core Insights - Prenetics Global Limited has successfully priced a public offering of approximately $48 million, involving 2,992,596 Class A ordinary shares and warrants [1][2] - The company aims to leverage its rapid growth in the health supplement sector, particularly through its brand IM8, which achieved $100 million in annual recurring revenue within 11 months of launch [5][21] - Prenetics is strategically focusing on its IM8 brand while considering divestment of other business units to maximize shareholder value [7] Financial Overview - The offering includes a double warrant structure, with Class A and Class B warrants exercisable at premiums of 50% and 100% respectively, potentially raising total proceeds to approximately $216 million if fully exercised [2] - IM8 is projected to generate revenues between $160 million and $200 million in 2026, with a current monthly revenue run rate of over $8.6 million [15][13] - Following the offering, Prenetics will hold approximately $100 million in cash and 275 BTC valued at $31 million, totaling $131 million in liquidity [16] Strategic Partnerships - The offering was supported by notable investors including Kraken, American Ventures, and Jihan Wu's GPTX, enhancing Prenetics' strategic positioning in the cryptocurrency and health sectors [3][6] - Aryna Sabalenka, a world-renowned tennis champion, has increased her stake in Prenetics, further aligning her brand with the company's mission [4][8] Market Positioning - IM8 is recognized as the fastest-growing supplement brand globally, with significant traction across multiple markets, targeting a share of the $704 billion global supplements market expected by 2030 [5][21] - The company is pioneering a Bitcoin treasury strategy, purchasing 1 BTC daily, which positions it at the intersection of health innovation and digital assets [22]

Core Viewpoint - Prenetics Global Limited has successfully priced a public offering to raise approximately $48 million, which will be used for global expansion and strategic Bitcoin accumulation as part of its health and wealth strategy [1][3]. Group 1: Offering Details - The offering includes 2,992,596 Class A ordinary shares and associated warrants at a combined price of $16.08 per share [1]. - Class A Common Warrants have an exercise price of $24.12 per share, while Class B Common Warrants are priced at $32.16 per share, representing premiums of 50% and 100% respectively [2]. - The offering is expected to close on October 28, 2025, pending customary closing conditions [3]. Group 2: Use of Proceeds - Proceeds from the offering will be allocated to the global expansion of IM8, Prenetics' flagship consumer brand, which has achieved rapid growth [3]. - The company is also focusing on accumulating Bitcoin, having established a Bitcoin Treasury and purchasing 1 Bitcoin per day, totaling 275 BTC as of October 27, 2025 [8]. Group 3: Company Background - Prenetics is recognized as a leading health sciences company, co-founded with David Beckham, and has rapidly grown its IM8 brand to reach $100 million in annual recurring revenue within 11 months of launch [7]. - The company is pioneering the intersection of health innovation and digital assets, positioning itself uniquely in the market [8].

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Click Holdings Limited (CLIK) is up 81% at $11.17 [3] - Avidity Biosciences, Inc. (RNA) is up 43% at $70.72 [3] - Dyne Therapeutics, Inc. (DYN) is up 37% at $23.58 [3] - Zenas BioPharma, Inc. (ZBIO) is up 21% at $29.00 [3] - ProPetro Holding Corp. (PUMP) is up 18% at $7.47 [3] - PepGen Inc. (PEPG) is up 17% at $5.35 [3] - Unusual Machines, Inc. (UMAC) is up 15% at $14.85 [3] - Semler Scientific, Inc. (SMLR) is up 14% at $27.32 [3] - ETHZilla Corporation (ETHZ) is up 13% at $20.51 [3] - Relmada Therapeutics, Inc. (RLMD) is up 13% at $2.38 [3] Premarket Losers - Smart Logistics Global Limited (SLGB) is down 37% at $3.21 [4] - MaxsMaking Inc. (MAMK) is down 22% at $4.08 [4] - Prenetics Global Limited (PRE) is down 14% at $14.40 [4] - United States Antimony Corporation (UAMY) is down 14% at $10.22 [4] - NeurAxis, Inc. (NRXS) is down 12% at $3.01 [4] - Obook Holdings Inc. (OWLS) is down 9% at $11.39 [4] - Qualigen Therapeutics, Inc. (QLGN) is down 9% at $3.30 [4] - Critical Metals Corp. (CRML) is down 8% at $13.70 [4] - Neuphoria Therapeutics Inc. (NEUP) is down 8% at $5.73 [4] - Beam Therapeutics Inc. (BEAM) is down 7% at $25.86 [4]

Core Viewpoint - Prenetics Global Limited has initiated a public offering of its Class A Ordinary Shares and common warrants to fund the global expansion of its IM8 brand and to accumulate Bitcoin as part of its health and wealth strategy [1][6]. Group 1: Offering Details - The offering is subject to market conditions, and there is no assurance regarding its completion or the actual size and terms [2]. - Dominari Securities LLC is the sole placement agent for the offering, which is made under an effective shelf registration statement declared effective by the SEC on September 11, 2025 [3]. Group 2: Company Overview - Prenetics is a leading health sciences company co-founded with David Beckham, focusing on health and longevity through its IM8 brand, which is one of the fastest-growing supplement brands globally [6]. - The company has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 272 BTC as of October 24, 2025, positioning itself at the intersection of health innovation and digital assets [6].